# CASTRO1 - Study on CRP Apheresis After Ischemic Stroke

> **NCT04417231** · NA · TERMINATED · sponsor: **Pentracor GmbH** · enrollment: 3 (actual)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **DEVICE:** CRP apheresis

## Key facts

- **NCT ID:** NCT04417231
- **Lead sponsor:** Pentracor GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-28
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** sufficient recruitment of study patients based on the existing (and repeatedly adjusted) inclusion and exclusion criteria is not possible within a reasonable period of time
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04417231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04417231, "CASTRO1 - Study on CRP Apheresis After Ischemic Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04417231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*